{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:06:21Z","timestamp":1786982781601,"version":"build-2736575974"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T00:00:00Z","timestamp":1637798400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T00:00:00Z","timestamp":1637798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Diagn Ther"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s40291-021-00566-y","type":"journal-article","created":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T14:03:41Z","timestamp":1637849021000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Neurofilament Light Chain as a Biomarker in Cerebral Small-Vessel Disease"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8451-7389","authenticated-orcid":false,"given":"Nils","family":"Peters","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,25]]},"reference":[{"issue":"1","key":"566_CR1","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0006-8993(03)03219-0","volume":"987","author":"N Norgren","year":"2003","unstructured":"Norgren N, Rosengren L, Stigbrand T. Elevated neurofilament levels in neurological diseases. Brain Res. 2003;987(1):25\u201331.","journal-title":"Brain Res"},{"issue":"2","key":"566_CR2","doi-asserted-by":"publisher","first-page":"228","DOI":"10.5853\/jos.2017.02565","volume":"20","author":"M Duering","year":"2018","unstructured":"Duering M, Konieczny MJ, Tiedt S, et al. Serum neurofilament light chain levels are related to small vessel disease burden. J Stroke. 2018;20(2):228\u201338.","journal-title":"J Stroke"},{"issue":"3","key":"566_CR3","doi-asserted-by":"publisher","first-page":"369","DOI":"10.5853\/jos.2019.02845","volume":"22","author":"N Peters","year":"2020","unstructured":"Peters N, van Leijsen E, Tuladhar AM, et al. Serum neurofilament light chain is associated with incident lacunes in progressive cerebral small vessel disease. J Stroke. 2020;22(3):369\u201376.","journal-title":"J Stroke"},{"key":"566_CR4","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aay1913","author":"TF Gendron","year":"2020","unstructured":"Gendron TF, Badi MK, Heckman MG, et al. Plasma neurofilament light predicts mortality in patients with stroke. Sci Transl Med. 2020. https:\/\/doi.org\/10.1126\/scitranslmed.aay1913.","journal-title":"Sci Transl Med"},{"issue":"4","key":"566_CR5","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.3233\/JAD-190615","volume":"72","author":"SY Wang","year":"2019","unstructured":"Wang SY, Chen W, Xu W, et al. Neurofilament light chain in cerebrospinal fluid and blood as a biomarker for neurodegenerative diseases: a systematic review and meta-analysis. J Alzheimers Dis. 2019;72(4):1353\u201361.","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"566_CR6","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1002\/ana.24954","volume":"81","author":"G Disanto","year":"2017","unstructured":"Disanto G, Barro C, Benkert P, Naegelin Y, Schadelin S, Giardiello A, et al. Serum neurofilament light: a biomarker of neuronal damage in multiple sclerosis. Ann Neurol. 2017;81(6):857\u201370.","journal-title":"Ann Neurol"},{"key":"566_CR7","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1212\/WNL.0000000000001642","volume":"84","author":"CH Lu","year":"2015","unstructured":"Lu CH, Macdonald-Wallis C, Gray E, Pearce N, Petzold A, Norgren N, et al. Neurofilament light chain: a prognostic biomarker in amyotrophic lateral sclerosis. Neurology. 2015;84:2247\u201357.","journal-title":"Neurology"},{"key":"566_CR8","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1001\/jamaneurol.2016.6117","volume":"74","author":"N Mattsson","year":"2017","unstructured":"Mattsson N, Andreasson U, Zetterberg H, Blennow K, Alzheimer\u2019s Disease Neuroimaging Initiative. Association of plasma neurofilament light with neurodegeneration in patients with Alzheimer disease. JAMA Neurol. 2017;74:557\u201366.","journal-title":"JAMA Neurol"},{"key":"566_CR9","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1212\/WNL.0000000000003154","volume":"87","author":"JD Rohrer","year":"2016","unstructured":"Rohrer JD, Woollacott IO, Dick KM, Brotherhood E, Gordon E, Fellows A, et al. Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia. Neurology. 2016;87:1329\u201336.","journal-title":"Neurology"},{"issue":"10","key":"566_CR10","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1212\/WNL.0000000000003680","volume":"88","author":"O Hansson","year":"2017","unstructured":"Hansson O, Janelidze S, Hall S, Magdalinou N, Lees AJ, Andreasson U, et al. Blood-based NfL: a biomarker for differential diagnosis of parkinsonian disorder. Neurology. 2017;88(10):930\u20137.","journal-title":"Neurology"},{"key":"566_CR11","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1001\/jamaneurol.2019.0765","volume":"76","author":"N Mattsson","year":"2019","unstructured":"Mattsson N, Cullen NC, Andreasson U, Zetterberg H, Blennow K. Association between longitudinal plasma neurofilament light and neurodegeneration in patients with Alzheimer disease. JAMA Neurol. 2019;76:791\u20139.","journal-title":"JAMA Neurol"},{"issue":"1","key":"566_CR12","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.1212\/WNL.0000000000004761","volume":"90","author":"E Feneberg","year":"2018","unstructured":"Feneberg E, Oeckl P, Steinacker P, Verde F, Barro C, Van Damme P, et al. Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosis. Neurology. 2018;90(1):e22-30.","journal-title":"Neurology"},{"issue":"14","key":"566_CR13","doi-asserted-by":"publisher","first-page":"e1338","DOI":"10.1212\/WNL.0000000000006282","volume":"91","author":"S Tiedt","year":"2018","unstructured":"Tiedt S, Duering M, Barro C, Kaya AG, Boeck J, Bode FJ, et al. Serum neurofilament light: a biomarker of neuroaxonal injury after ischemic stroke. Neurology. 2018;91(14):e1338\u201347.","journal-title":"Neurology"},{"key":"566_CR14","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S1474-4422(10)70104-6","volume":"9","author":"L Pantoni","year":"2010","unstructured":"Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9:689\u2013701.","journal-title":"Lancet Neurol"},{"issue":"8","key":"566_CR15","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/S1474-4422(13)70124-8","volume":"12","author":"JM Wardlaw","year":"2013","unstructured":"Wardlaw JM, Smith EE, Biessels GJ, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12(8):822\u201338.","journal-title":"Lancet Neurol"},{"issue":"1","key":"566_CR16","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1177\/2396987319888016","volume":"5","author":"L Hert","year":"2020","unstructured":"Hert L, Polymeris AA, Schaedelin S, et al. Small vessel disease is associated with an unfavourable outcome in stroke patients on oral anticoagulation. Eur Stroke J. 2020;5(1):63\u201372.","journal-title":"Eur Stroke J"},{"issue":"10","key":"566_CR17","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1515\/cclm-2015-1195","volume":"54","author":"J Kuhle","year":"2016","unstructured":"Kuhle J, Barro C, Andreasson U, et al. Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa. Clin Chem Lab Med. 2016;54(10):1655\u201361.","journal-title":"Clin Chem Lab Med"},{"key":"566_CR18","doi-asserted-by":"publisher","first-page":"109281","DOI":"10.1016\/j.jneumeth.2021.109281","volume":"361","author":"C Barro","year":"2021","unstructured":"Barro C, Zetterberg H. The blood biomarkers puzzle: a review of protein biomarkers in neurodegenerative diseases. J Neurosci Methods. 2021;361:109281.","journal-title":"J Neurosci Methods"},{"issue":"5","key":"566_CR19","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1002\/acn3.51355","volume":"8","author":"A Gauthier","year":"2021","unstructured":"Gauthier A, Viel S, Perret M, et al. Comparison of Simoa\u2122 and Ella\u2122 to assess serum neurofilament-light chain in multiple sclerosis. Ann Clin Transl Neurol. 2021;8(5):1141\u201350.","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"566_CR20","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/s41467-020-14612-6","volume":"11","author":"M Khalil","year":"2020","unstructured":"Khalil M, Pirpamer L, Hofer E, et al. Serum neurofilament light levels in normal aging and their association with morphologic brain changes. Nat Commun. 2020;11(1):812.","journal-title":"Nat Commun"},{"issue":"6","key":"566_CR21","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1002\/ana.24954","volume":"81","author":"G Disanto","year":"2017","unstructured":"Disanto G, Barro C, Benkert P, et al. Serum neurofilament light: a biomarker of neuronal damage in multiple sclerosis. Ann Neurol. 2017;81(6):857\u201370.","journal-title":"Ann Neurol"},{"key":"566_CR22","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.neurobiolaging.2012.04.019","volume":"34","author":"N Zieren","year":"2013","unstructured":"Zieren N, Duering M, Peters N, Reyes S, Jouvent E, Herv\u00e9 D, et al. Education modifies the relation of vascular pathology to cognitive function: cognitive reserve in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Neurobiol Aging. 2013;34:400\u20137.","journal-title":"Neurobiol Aging"},{"key":"566_CR23","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1212\/01.wnl.0000216270.02610.7e","volume":"66","author":"RA Charlton","year":"2006","unstructured":"Charlton RA, Morris RG, Nitkunan A, Markus HS. The cognitive profiles of CADASIL and sporadic small vessel disease. Neurology. 2006;66:1523\u20136.","journal-title":"Neurology"},{"issue":"11","key":"566_CR24","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1176\/appi.ajp.162.11.2078","volume":"162","author":"N Peters","year":"2005","unstructured":"Peters N, Opherk C, Danek A, Ballard C, Herzog J, Dichgans M. The pattern of cognitive performance in CADASIL: a monogenic condition leading to subcortical ischemic vascular dementia. Am J Psychiatry. 2005;162(11):2078\u201385.","journal-title":"Am J Psychiatry"},{"issue":"20","key":"566_CR25","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1212\/WNL.0000000000004645","volume":"89","author":"T Gattringer","year":"2017","unstructured":"Gattringer T, Pinter D, Enzinger C, et al. Serum neurofilament light is sensitive to active cerebral small vessel disease. Neurology. 2017;89(20):2108\u201314.","journal-title":"Neurology"},{"key":"566_CR26","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1161\/STROKEAHA.116.015750","volume":"48","author":"Y Ling","year":"2017","unstructured":"Ling Y, De Guio F, Duering M, Jouvent E, Herv\u00e9 D, Godin O, et al. Predictors and clinical impact of incident lacunes in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Stroke. 2017;48:283\u20139.","journal-title":"Stroke"},{"key":"566_CR27","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/1471-2377-13-203","volume":"13","author":"L Blanco-Rojas","year":"2013","unstructured":"Blanco-Rojas L, Arboix A, Canovas D, Grau-Olivares M, Oliva Morera JC, Parra O. Cognitive profile in patients with a first-ever lacunar infarct with and without silent lacunes: a comparative study. BMC Neurol. 2013;13:203.","journal-title":"BMC Neurol"},{"key":"566_CR28","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1177\/0271678X18775215","volume":"39","author":"D Pinter","year":"2019","unstructured":"Pinter D, Gattringer T, Enzinger C, Seifert-Held T, Kneihsl M, Fandler S, et al. Longitudinal MRI dynamics of recent small subcortical infarcts and possible predictors. J Cereb Blood Flow Metab. 2019;39:1669\u201377.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"11","key":"566_CR29","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1007\/s00415-019-09477-9","volume":"266","author":"A Pedersen","year":"2019","unstructured":"Pedersen A, Stanne TM, Nilsson S, Klasson S, Rosengren L, Holmegaard L, et al. Circulating neurofilament light in ischemic stroke: temporal profile and outcome prediction. J Neurol. 2019;266(11):2796\u2013806.","journal-title":"J Neurol"},{"issue":"4","key":"566_CR30","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/s12640-019-00159-y","volume":"37","author":"P Wang","year":"2020","unstructured":"Wang P, Fan J, Yuan L, Nan Y, Nan S. Serum neurofilament light predicts severity and prognosis in patients with ischemic stroke. Neurotox Res. 2020;37(4):987\u201395.","journal-title":"Neurotox Res"},{"issue":"7","key":"566_CR31","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1161\/STROKEAHA.119.024941","volume":"50","author":"FK Korley","year":"2019","unstructured":"Korley FK, Goldstick J, Mastali M, Van Eyk JE, Barsan W, Meurer WJ, et al. Serum NfL (neurofilament light chain) levels and incident stroke in adults with diabetes mellitus. Stroke. 2019;50(7):1669\u201375.","journal-title":"Stroke"},{"issue":"1","key":"566_CR32","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12974-020-01813-5","volume":"17","author":"CH Chen","year":"2020","unstructured":"Chen CH, Cheng YW, Chen YF, Tang SC, Jeng JS. Plasma neurofilament light chain and glial fibrillary acidic protein predict stroke in CADASIL. J Neuroinflammation. 2020;17(1):124.","journal-title":"J Neuroinflammation"},{"issue":"6","key":"566_CR33","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1136\/jnnp-2020-325681","volume":"92","author":"M Egle","year":"2021","unstructured":"Egle M, Loubiere L, Maceski A, Kuhle J, Peters N, Markus HS. Neurofilament light chain predicts future dementia risk in cerebral small vessel disease. J Neurol Neurosurg Psychiatry. 2021;92(6):582\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"566_CR34","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/ana.24758","volume":"80","author":"E Baykara","year":"2016","unstructured":"Baykara E, Gesierich B, Adam R, Tuladhar AM, Biesbroek JM, Koek HL, et al. A novel imaging marker for small vessel disease based on skeletonization of white matter tracts and diffusion histograms. Ann Neurol. 2016;80:581\u201392.","journal-title":"Ann Neurol"},{"key":"566_CR35","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/jcbfm.2015.113","volume":"36","author":"P Benjamin","year":"2016","unstructured":"Benjamin P, Zeestraten E, Lambert C, Ster IC, Williams OA, Lawrence AJ, et al. Progression of MRI markers in cerebral small vessel disease: sample size considerations for clinical trials. J Cereb Blood Flow Metab. 2016;36:228\u201340.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"10","key":"566_CR36","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1212\/01.wnl.0000216271.96364.50","volume":"66","author":"N Peters","year":"2006","unstructured":"Peters N, Holtmannsp\u00f6tter M, Opherk C, Gschwendtner A, Herzog J, S\u00e4mann P, et al. Brain volume changes in CADASIL: a serial MRI study in pure subcortical ischemic vascular disease. Neurology. 2006;66(10):1517\u201322.","journal-title":"Neurology"}],"container-title":["Molecular Diagnosis & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-021-00566-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40291-021-00566-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-021-00566-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T05:49:52Z","timestamp":1642484992000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40291-021-00566-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,25]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["566"],"URL":"https:\/\/doi.org\/10.1007\/s40291-021-00566-y","relation":{},"ISSN":["1177-1062","1179-2000"],"issn-type":[{"value":"1177-1062","type":"print"},{"value":"1179-2000","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,25]]},"assertion":[{"value":"10 November 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author has no funding to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}